Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Pha…

Biotechnology

US, Waltham [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

XLO M&As
Biotechnology M&A

M&A Deals · Breakdown

Xilio Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Xilio Therapeutics, Inc. has no acquisition track records yet.